Search Results - "You, Liangshun"

Uncertainties about the transmission routes of 2019 novel coronavirus by Han, Qingmei, Lin, Qingqing, Ni, Zuowei, You, Liangshun

“…[...]it was reported that SARS‐CoV‐2 was also founded on the surface of the door handles, cell phones, and other items in the residential sites of confirmed…”
Get full text

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection by Lin, Qingqing, Zhu, Li, Ni, Zuowei, Meng, Haitao, You, Liangshun

Get full text

Decitabine-Mediated Epigenetic Reprograming Enhances Anti-leukemia Efficacy of CD123-Targeted Chimeric Antigen Receptor T-Cells by You, Liangshun, Han, Qingmei, Zhu, Li, Zhu, Yijing, Bao, Changqian, Yang, Chunmei, Lei, Wen, Qian, Wenbin

“…Chimeric antigen receptor (CAR) T cells represent a potentially curative therapy for patients with advanced hematological cancers; however, uncertainties…”
Get full text

Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo by Chen, Zhenzhen, You, Liangshun, Wang, Lei, Huang, Xianbo, Liu, Hui, Wei, Ju Ying, Zhu, Li, Qian, Wenbin

“…Exosomes derived from tumor cells (TEXs) are involved in both immune suppression, angiogenesis, metastasis and anticancer stimulatory, but the biological…”
Get full text

Autophagy, autophagy-associated adaptive immune responses and its role in hematologic malignancies by You, Liangshun, Jin, Shenhe, Zhu, Li, Qian, Wenbin

“…Autophagy is a tightly regulated catabolic process that leads to the degradation of cytoplasmatic components such as aggregated/misfolded proteins and…”
Get full text

Trends in mortality from infection among patients with hematologic malignancies: differences according to hematologic malignancy subtype by Yin, Xuejiao, Hu, Xuelian, Tong, Hongyan, You, Liangshun

“…Background: Infection is the most important cause of non-relapse mortality in hematologic malignancy patients, leading to increased costs and prolonged…”
Get full text

The mechanisms and cross-protection of trained innate immunity by Hu, Shiwei, Xiang, Danhong, Zhang, Xinlu, Zhang, Lan, Wang, Shengjie, Jin, Keyi, You, Liangshun, Huang, Jian

“…In recent years, the traditional cognition of immunological memory being specific to adaptive immunity has been challenged. Innate immunity can mount enhanced…”
Get full text

Global, Regional, and National Burden of Chronic Myeloid Leukemia, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017 by Lin, Qingqing, Mao, Liping, Shao, Li, Zhu, Li, Han, Qingmei, Zhu, Honghu, Jin, Jie, You, Liangshun

“…With the advent of tyrosine kinase inhibitors (TKIs), the prognosis of chronic myeloid leukemia (CML) seems to have dramatically improved over the last two…”
Get full text

Bispecific T cell engagers targeting CD20/CD3 in B-cell lymphoma: latest updates from 2023 EHA annual meeting by Jin, Shenhe, Liu, Yi, Zhang, Ye, Zhou, Fengping, You, Liangshun, Zhang, Jin

Get full text

Bispecific antibody treatment of multiple myeloma: latest updates from the 2022 ASH annual meeting by Yin, Xuejiao, Liu, Yi, Sun, Jianai, Tong, Hongyan, Meng, Haitao, You, Liangshun

“…Background: Effective novel therapies for multiple myeloma (MM) patients who are unresponsive to conventional treatments (triple-class refractory) are an…”
Get full text

Harnessing Nanotechnology: Emerging Strategies for Multiple Myeloma Therapy by Yang, Min, Chen, Yu, Zhu, Li, You, Liangshun, Tong, Hongyan, Meng, Haitao, Sheng, Jianpeng, Jin, Jie

“…Advances in nanotechnology have provided novel avenues for the diagnosis and treatment of multiple myeloma (MM), a hematological malignancy characterized by…”
Get full text

Gut Microbiome and Metabolome Were Altered and Strongly Associated With Platelet Count in Adult Patients With Primary Immune Thrombocytopenia by Zhang, Xuewu, Gu, Silan, You, Liangshun, Xu, Yu, Zhou, De, Chen, Yunbo, Yan, Ren, Jiang, Huiyong, Li, Yating, Lv, Longxian, Qian, Wenbin

“…Gut microbiota has been implicated in the pathogenesis of many autoimmune diseases. This is still an area of active research given that the role of gut…”
Get full text

Continuous therapy in HHV-8 negative Multicentric Castleman Disease and prolonged progression-free survival by Liu, Yi, Yin, Xuejiao, Ding, Shengnan, Ge, Jiaying, Ma, Liya, Yang, Min, Luo, Xuxia, Zhong, Chengli, Fang, Sishi, Yao, Qiumei, Zhu, Li, Yu, Wenjuan, Mao, Liping, Wei, Juying, Ye, Xingnong, Zhou, De, Tong, Hongyan, Meng, Haitao, Jin, Jie, You, Liangshun

“…The optimal treatment endpoints and duration of continuous therapy for multicentric Castleman disease (MCD) remain controversial. We retrospectively analyzed…”
Get full text

The crosstalk between autophagic and endo-/exosomal pathways in antigen processing for MHC presentation in anticancer T cell immune responses by You, Liangshun, Mao, Liping, Wei, Juying, Jin, Shenhe, Yang, Chunmei, Liu, Hui, Zhu, Li, Qian, Wenbin

“…T cells recognize antigen fragments from proteolytic products that are presented to them in the form of peptides on major histocompatibility complex (MHC)…”
Get full text

Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia by Tong, Yin, You, Liangshun, Liu, Hui, Li, Lu, Meng, Haitao, Qian, Qijun, Qian, Wenbin

“…An attractive strategy among adenovirus-based oncolytic systems is to design adenoviral vectors to express pro-apoptotic genes, in which this gene-virotherapy…”
Get full text

When idiopathic multicentric Castleman disease meets COVID-19: a multicenter retrospective study from China by Liu, Yi, Yin, Xuejiao, Xu, Dan, Lv, Yunfei, Zhu, Li, Yang, Min, Yao, Qiumei, Jin, Jie, Huang, Li, Meng, Haitao, You, Liangshun

“…Idiopathic multicentric Castleman disease (iMCD) is a rare and cytokine storm-driven inflammatory disorder. The exact cause of iMCD is still unknown, although…”
Get full text

Downregulation of Mcl-1 synergizes the apoptotic response to combined treatment with cisplatin and a novel fiber chimeric oncolytic adenovirus by YOU, LIANGSHUN, WANG, YING, JIN, YINGMING, QIAN, WENBIN

“…The aim of this study was to examine the effects of SG511, a novel fiber chimeric oncolytic adenovirus with E1B 55-kDa deleted, combined with cisplatin on…”
Get full text

Coronavirus 2019-nCoV: A brief perspective from the front line by Han, Qingmei, Lin, Qingqing, Jin, Shenhe, You, Liangshun

“…A novel coronavirus, designated as 2019-nCoV, hit the central Chinese city of Wuhan in late December 2019, and subsequently spread rapidly to all provinces of…”
Get full text

Role of Radiation Therapy in Mortality among Adolescents and Young Adults with Lymphoma: Differences According to Cause of Death by Yin, Xuejiao, You, Liangshun, Hu, Xuelian

“…Background: Despite its efficacy, emerging concerns exist regarding radiation therapy (RT)-associated toxicity in adolescent and young adult (AYA) lymphoma…”
Get full text

Prognosis Influence of Additional Chromosome Abnormalities in Newly Diagnosed Acute Promyelocytic Leukemia with t(15;17)(q22;q21) by Liu, Lin, Wang, Jinghan, Xu, Huan, Zhao, Shuqi, You, Liangshun, Huang, Jiansong, Jin, Jie

“…The therapeutic advancements over the last decade have dramatically improved the prognosis and decreased the mortality of acute promyelocytic leukemia (APL)…”
Get full text